门诊乳房手术后阿片类药物使用:医生是否也是问题的一部分?
这项前瞻性研究纳入连续接受二期乳房再造(n=60)或乳房缩小(n=35)的患者,术后给予30片羟考酮5.0mg/对乙酰氨基酚325mg。二期乳房再造组平均消耗11.4片、剩余18.6片,乳房缩小组平均消耗17.5片、剩余12.5片,全队列在术后30天以上剩余1551片。作者认为门诊乳房手术后开具30片阿片类药物似乎不必要且过量。
要点
- 二期乳房再造组61.5%在术后第5天已停用阿片类药物。
- 二期乳房再造平均消耗11.4片,乳房缩小平均消耗17.5片。
- 全队列术后30天以上剩余1551片未使用药片。
核心结论
- 常用的疼痛方案为乳房手术提供了足够的疼痛缓解和满意度,但剩余大量药片,医生作为处方者应意识到这种差异。
- 门诊乳房手术后开具30片阿片类药物似乎不必要且过量。
研究设计与样本
- 前瞻性研究,连续纳入接受二期乳房再造(n=60)或乳房缩小(n=35)的患者。
- 术后给予30片羟考酮5.0mg/对乙酰氨基酚325mg,术前有过敏或正在使用麻醉药的患者被排除。
- 在术后第3至5天、第8至10天及第30天或以上进行三次联系,询问麻醉药使用、疼痛水平(0至10)和疼痛控制满意度。
主要发现
- 二期乳房再造组中61.5%在术后第5天已停用阿片类药物。
- 二期乳房再造患者平均消耗11.4片,乳房缩小患者平均消耗17.5片。
- 术后30天以上,多数患者经历非常轻微的疼痛,乳房缩小后改善3.74分。
- 二期乳房再造和乳房缩小每例患者分别剩余18.6片和12.5片。
- 全队列在术后30天以上共剩余1551片未使用药片。
临床怎么用
- 作者认为门诊乳房手术后开具30片阿片类药物似乎不必要且过量,医生作为处方者应意识到这种差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The increasing rate of opioid abuse warrants standardization of postoperative pain management. The purpose of this study was to analyze the use of opioids in pain control and patient satisfaction following ambulatory breast surgery. METHODS: This was a prospective study of a consecutive series of patients undergoing secondary breast reconstruction (n = 60) or breast reduction (n = 35). All patients were given a pain questionnaire preoperatively. Postoperatively, women received 30 tablets of oxycodone 5.0 mg/acetaminophen 325 mg. Patients were contacted three times: postoperative days 3 to 5, 8 to 10, and 30 or higher. All patients were queried on narcotic use, pain level (0 to 10), and satisfaction with pain control. Patients with allergies or taking narcotics preoperatively were excluded. RESULTS: Most in the secondary breast reconstruction group (61.5 percent) had stopped taking opioids by postoperative day 5. Patients consumed a mean of 11.4 tablets following secondary breast reconstruction and a mean of 17.5 tablets after breast reduction. A majority reported feeling satisfied with their pain management. At postoperative day greater than 30, most experienced very mild pain, with an improvement of 3.74 points following breast reduction. There were 18.6 and 12.5 tablets per patient left over for secondary breast reconstruction and breast reduction, respectively. A total of 1551 unused tablets were left over for the entire cohort at postoperative day greater than 30. There was no significant difference in average pain scores or interference with enjoyment or activity between those who did or did not take pain medication. CONCLUSIONS: This commonly prescribed pain regimen provides adequate pain relief and satisfaction for breast surgery, with a substantial number of leftover tablets. Physicians as prescribers should be aware of discrepancies. Prescription of 30 opioid tablets after outpatient breast surgery appears unnecessary and excessive. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Hart AM, Broecker JS, Kao L, et al. Opioid Use following Outpatient Breast Surgery: Are Physicians Part of the Problem? Plast Reconstr Surg. 2018. PMID: 29878998. doi:10.1097/PRS.0000000000004636
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。